FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 358:1851-1853 April 24, 2008 Number 17 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Seung, K. B. PubMed Citation

A recent meta-analysis, report, and editorial all agreed with the need for a randomized trial of percutaneous coronary intervention (PCI) as compared with coronary-artery bypass grafting (CABG) in patients with left main coronary artery disease.^1,2,3 The meta-analysis reported results of 16 observational studies on 1278 patients undergoing PCI with drug-eluting stents for unprotected left main coronary artery disease.¹ Mortality was 2.3% during hospitalization and 5.5% at the time of last follow-up, at a median of 10 months. Five randomized comparisons of PCI and CABG were noted to be ongoing, with combined enrollment goals exceeding 2400 patients with unprotected left main . . . [Full Text of this Article]

Source Information

This article (10.1056/NEJMe0802094) was published at www.nejm.org on March 31, 2008.

From the Department of Surgery, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC.

This article has been cited by other articles:

• (2008). Stenting for Left Main Coronary Artery Disease?. JWatch General 2008: 2-2 [Full Text]